信诺旗下快捷药方公司与美国联邦贸易委员会就胰岛素定价指控达成和解——路透社文件披露

美股速递
Feb 05

信诺保险旗下的药品福利管理公司快捷药方,已就美国联邦贸易委员会提出的胰岛素定价相关指控达成和解。据路透社查阅的一份文件显示,双方已就此事达成协议。

该和解协议标志着联邦贸易委员会对胰岛素产品定价实践调查的一个重要节点。快捷药方作为信诺集团的关键业务单元,其运营一直备受关注。

此次和解细节尚未完全公开,但无疑将影响药品福利管理行业的合规走向。市场密切关注后续发展,以评估其对行业定价模式的潜在影响。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10